The Douglas Mental Health University Institute is a Canadian psychiatric hospital located in the borough of Verdun in the city of Montreal, Quebec. It is also a teaching hospital affiliated with McGill University. The nearest Montreal Metro station is Monk.

During the past decade, Douglas Hospital Research Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Douglas Hospital Research Centre" #1 sponsor was "Douglas Mental Health University Institute" with 2 trials, followed by "Biogen" with 1 trials sponsored, "Centre for Addiction and Mental Health" with 1 trials sponsored, "Green Valley (Shanghai) Pharmaceuticals Co., Ltd." with 1 trials sponsored and "Sanofi" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Douglas Hospital Research Centre" #1 collaborator was "McGill University" with 2 trials as a collaborator, "Douglas Hospital Research Centre" with 1 trials as a collaborator, "Douglas Mental Health University Institute" with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator and "Lawson Health Research Institute" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Douglas Hospital Research Centre" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (2 trials), "Mild Cognitive Impairment Due to Alzheimer Disease" (2 trials), "Age-related Cognitive Decline" (1 trials) and "Aggression" (1 trials). Many other conditions were trialed in "Douglas Hospital Research Centre" in a lesser frequency.

Most popular intervention types in "Douglas Hospital Research Centre" are "Drug" (5 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Aducanumab (BIIB037)" (1 trials), "GV-971" (1 trials), "Inactivated negative ion generator" (1 trials) and "Litebook treatment devices" (1 trials). Other intervention names were less common.

The vast majority of trials in "Douglas Hospital Research Centre" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Douglas Hospital Research Centre". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Douglas Hospital Research Centre, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Douglas Hospital Research Centre, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".